BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Homeida MM, Malcolm SB, ElTayeb AZ, Eversole RR, Elassad AS, Geary TG, Ali MM, Mackenzie CD. The lack of influence of food and local alcoholic brew on the blood level of Mectizan(®) (ivermectin). Acta Trop 2013;127:97-100. [PMID: 23583861 DOI: 10.1016/j.actatropica.2013.03.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Duthaler U, Leisegang R, Karlsson MO, Krähenbühl S, Hammann F. The effect of food on the pharmacokinetics of oral ivermectin. J Antimicrob Chemother 2020;75:438-40. [PMID: 31691813 DOI: 10.1093/jac/dkz466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Boullata JI. Drug-Nutrition Interactions in Infectious Diseases. Nutrition and Infectious Diseases 2021. [DOI: 10.1007/978-3-030-56913-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Boullata JI. Drug-nutrition interactions. Reference Module in Food Science 2021. [DOI: 10.1016/b978-0-12-821848-8.00012-3] [Reference Citation Analysis]
4 Chaccour C, Abizanda G, Irigoyen-Barrio Á, Casellas A, Aldaz A, Martínez-Galán F, Hammann F, Gil AG. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. Sci Rep 2020;10:17073. [PMID: 33051517 DOI: 10.1038/s41598-020-74084-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
5 Al Jalali V, Zeitlinger M. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents. Clin Pharmacokinet 2020;59:827-47. [PMID: 32100246 DOI: 10.1007/s40262-020-00871-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Makenga Bof JC, Muteba D, Mansiangi P, Ilunga-Ilunga F, Coppieters Y. Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo. BMC Pharmacol Toxicol 2019;20:49. [PMID: 31420005 DOI: 10.1186/s40360-019-0327-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Verrest L, Dorlo TPC. Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review. Clin Pharmacokinet 2017;56:583-606. [PMID: 27744580 DOI: 10.1007/s40262-016-0467-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
8 Schulz JD, Neodo A, Coulibaly JT, Keiser J. Development and validation of a LC-MS/MS method for ivermectin quantification in dried blood spots: application to a pharmacokinetic study in Trichuris trichiura -infected adults. Anal Methods 2018;10:2901-9. [DOI: 10.1039/c8ay00828k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J 2017;16:161. [PMID: 28434401 DOI: 10.1186/s12936-017-1801-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 10.5] [Reference Citation Analysis]